Investor presentation and Confirmation of AGM

About this update from Cambridge Nutritional Sciences Plc

  OMEGA DIAGNOSTICS GROUP PLC ("Omega" or the "Company" or the "Group")   Investor presentation and Confirmation of AGM   Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health & Nutrition and Global Health products, provides the following details on the Investor presentation and Company's Annual General Meeting ("AGM").   Investor presentation Jag Grewal (CEO) and  Chris Lea (CFO) will provide a live presentation covering the preliminary results, which were issued yesterday, via the Investor Meet Company platform on Wednesday 14 September 2022 at 12pm.   The presentation is open to all existing and potential shareholders. Investors can sign up to Investor Meet Company for free and add to meet Omega Diagnostics Group plc via:   https://www.investormeetcompany.com/omega-diagnostics-group-plc/register-investor   Investors who already follow Omega Diagnostics Group plc on the Investor Meet Company platform will automatically be invited.   Annual General Meeting The Company confirms it will host its AGM at Poets House, St Mary's Street, Ely, CB7 4EY on Wednesday 26 October 2022 at 11.00am.     Contacts:  Omega Diagnostics Group PLC  www.omegadx.com Jag Grewal, Chief Executive Officer  via Walbrook PR Chris Lea, Chief Financial Officer finnCap Ltd   Tel: 020 7220 0500 Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance) Alice Lane/ Charlotte Sutcliffe (ECM) Walbrook PR Limited Tel: 020 7933 8780 or [email protected] Paul McManus Mob: 07980 541 893 Lianne Applegarth Mob: 07584 391 303 Sam Allen Mob: 07502 558 258   About Omega Diagnostics Group PLC Omega manufactures and distributes high quality in-vitro diagnostic products for use in hospitals, clinics, laboratories and healthcare practitioners in over 70 countries and specialise in the areas of health and nutrition and global health. www.omegadx.com  

View stock analysis, news, and events for Cambridge Nutritional Sciences Plc